DE69626290D1 - Hemmung von gefässverengungen nach eingriffen an den gefässen - Google Patents
Hemmung von gefässverengungen nach eingriffen an den gefässenInfo
- Publication number
- DE69626290D1 DE69626290D1 DE69626290T DE69626290T DE69626290D1 DE 69626290 D1 DE69626290 D1 DE 69626290D1 DE 69626290 T DE69626290 T DE 69626290T DE 69626290 T DE69626290 T DE 69626290T DE 69626290 D1 DE69626290 D1 DE 69626290D1
- Authority
- DE
- Germany
- Prior art keywords
- matrix
- cells
- implanted
- blood vessel
- endothelial cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/458,978 US5766584A (en) | 1995-06-02 | 1995-06-02 | Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells |
PCT/US1996/006707 WO1996038188A1 (en) | 1995-06-02 | 1996-05-09 | Inhibition of vascular occlusion following vascular intervention |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69626290D1 true DE69626290D1 (de) | 2003-03-27 |
DE69626290T2 DE69626290T2 (de) | 2003-12-04 |
Family
ID=23822888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69626290T Expired - Lifetime DE69626290T2 (de) | 1995-06-02 | 1996-05-09 | Hemmung von gefässverengungen nach eingriffen an den gefässen |
Country Status (8)
Country | Link |
---|---|
US (1) | US5766584A (de) |
EP (1) | EP0850073B1 (de) |
JP (2) | JP3941881B2 (de) |
AT (1) | ATE232748T1 (de) |
AU (1) | AU714559B2 (de) |
CA (1) | CA2222497C (de) |
DE (1) | DE69626290T2 (de) |
WO (1) | WO1996038188A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE502664T1 (de) | 1993-07-19 | 2011-04-15 | Angiotech Pharm Inc | Herstellungsmethode eines stents mit anti- angiogener zusammensetzung |
CN1219872A (zh) | 1996-05-24 | 1999-06-16 | 血管技术药物公司 | 治疗或预防身体通道疾病的组合物和方法 |
US20020077564A1 (en) * | 1996-07-29 | 2002-06-20 | Farallon Medsystems, Inc. | Thermography catheter |
US20080305999A1 (en) * | 1996-11-01 | 2008-12-11 | John Francis Martin | Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
US20040015069A1 (en) * | 1996-12-27 | 2004-01-22 | Brown David Lloyd | System for locating inflamed plaque in a vessel |
GB9809082D0 (en) * | 1998-04-28 | 1998-06-24 | Eurogene Limited | Delivery device |
US20030039694A1 (en) * | 1998-04-28 | 2003-02-27 | Martin John Francis | Periadventitial delivery device |
US6375680B1 (en) * | 1998-12-01 | 2002-04-23 | St. Jude Medical, Inc. | Substrates for forming synthetic tissues |
US6824549B1 (en) * | 2000-06-07 | 2004-11-30 | Iris Ginron Chao | Method & device for making reversed bypass with cultured vessel in situ |
US20040097990A1 (en) * | 1999-01-27 | 2004-05-20 | Zhao Iris Ginron | Graft material, device & method of making |
US6333347B1 (en) | 1999-01-29 | 2001-12-25 | Angiotech Pharmaceuticals & Advanced Research Tech | Intrapericardial delivery of anti-microtubule agents |
US6328762B1 (en) * | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
US6921412B1 (en) | 1999-05-18 | 2005-07-26 | Cryolife, Inc. | Self-supporting, shaped, three-dimensional biopolymeric materials and methods |
JP3603179B2 (ja) * | 1999-09-09 | 2004-12-22 | グンゼ株式会社 | 心血管系組織培養用基材および組織再生法 |
CA2396628A1 (en) | 2000-01-25 | 2001-08-02 | Edwards Lifesciences Corporation | Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
EP1328220B1 (de) * | 2000-10-24 | 2011-01-05 | CryoLife, Inc. | Bioprothetischer füller und methoden, insbesondere für die bildung von bandscheibenbioprothesen in situ |
US20040241211A9 (en) * | 2000-11-06 | 2004-12-02 | Fischell Robert E. | Devices and methods for reducing scar tissue formation |
AU2001297782B2 (en) | 2000-11-07 | 2006-03-02 | Cryolife, Inc. | Expandable foam-like biomaterials and methods |
BR0206464A (pt) | 2001-01-16 | 2005-01-18 | Vascular Therapies Llc | Aparelho e processos para impedir ou tratar insuficiência de acesso vascular para hemodiálise e outros enxertos vasculares |
JP3970013B2 (ja) * | 2001-12-14 | 2007-09-05 | 泰晴 野一色 | 管腔形成誘導性材料および体内挿入用器具 |
AU2003228808A1 (en) * | 2002-05-02 | 2003-11-17 | Regents Of The University Of Minnesota | Fibrin-based biomatrix |
JP4265888B2 (ja) * | 2002-06-12 | 2009-05-20 | 株式会社リコー | 画像形成装置 |
EP1610823B1 (de) | 2003-03-28 | 2011-09-28 | Innovational Holdings, LLC | Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle |
US8034048B2 (en) * | 2003-05-05 | 2011-10-11 | Boston Scientific Scimed, Inc. | Tissue patches and related delivery systems and methods |
US7416546B2 (en) * | 2003-05-05 | 2008-08-26 | Boston Scientific Scimed, Inc. | Tissue patches and related delivery systems and methods |
US8192348B2 (en) * | 2003-07-01 | 2012-06-05 | Regents Of The University Of Minnesota | Engineered blood vessels |
US7408014B2 (en) * | 2003-07-08 | 2008-08-05 | The Children's Hospital Of Philadelphia | Steroid lipid-modified polyurethane as an implantable biomaterial, the preparation and uses thereof |
KR101319227B1 (ko) * | 2003-10-10 | 2013-10-16 | 게 밍 루이 | 각막 내피세포 및 관련세포를 생체고분자 위에서성장시키고, 인공의 이식용 각막을 제조하는 방법 및조성물 |
US20050245905A1 (en) * | 2004-04-30 | 2005-11-03 | Schmidt Steven P | Local drug-delivery system |
JP5674256B2 (ja) * | 2004-12-08 | 2015-02-25 | シャイア リジェネラティブ メディシン, インコーポレイテッド | 細胞含有流動性組成物の最小侵襲投与のための材料および方法 |
AU2011211370B2 (en) * | 2004-12-08 | 2013-08-15 | Shire Regenerative Medicine, Inc. | Methods and compositions for enhancing vascular access |
EP1874919B1 (de) | 2005-04-21 | 2010-06-09 | Massachusetts Institute Of Technology | Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene, einschliesslich genidentischer und nicht-genidentischer zellen, gewebe oder organe |
AU2006262682B2 (en) | 2005-06-21 | 2012-07-05 | Shire Regenerative Medicine, Inc. | Methods and compositions for enhancing vascular access |
US20070100323A1 (en) * | 2005-10-31 | 2007-05-03 | Ludwig Florian N | Facilitation of endothelialization by in situ surface modification |
US20100204783A1 (en) * | 2005-12-06 | 2010-08-12 | Helen Marie Nugent | Methods and compositions for enhancing vascular access |
CA2668621A1 (en) * | 2006-11-07 | 2008-05-15 | Pervasis Therapeutics, Inc. | Materials and methods for treating and managing angiogenesis-mediated diseases |
US20080176206A1 (en) | 2007-01-18 | 2008-07-24 | Toshiharu Shinoka | Cardiovascular tissue culture substrate |
EP2155294B1 (de) * | 2007-06-13 | 2012-02-15 | Pervasis Therapeutics, Inc. | Verfahren und vorrichtungen zur minimal invasiven abgabe von zellhaltigen fliessfähigen zusammensetzungen |
US20100239671A1 (en) * | 2007-11-06 | 2010-09-23 | Edelman Elazer R | Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair |
US20110218606A1 (en) * | 2010-03-02 | 2011-09-08 | Medtronic Vascular, Inc. | Methods for Stabilizing Femoral Vessels |
US9114235B2 (en) | 2010-05-03 | 2015-08-25 | Cardiovascular Systems, Inc. | Therapeutic agent delivery system and method for localized application of therapeutic substances to a biological lumen |
FR2960784B1 (fr) | 2010-06-04 | 2012-07-20 | Univ Claude Bernard Lyon | Nouveaux substituts vasculaires biodegradables |
US9198975B2 (en) | 2010-12-01 | 2015-12-01 | The University Of North Carolina At Chapel Hill | Methods and compositions for targeting sites of neovascular growth |
CN111454467B (zh) * | 2020-02-18 | 2022-07-12 | 中国人民大学 | 一种涂抹式生物可降解血管外支架及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4418691A (en) * | 1981-10-26 | 1983-12-06 | Massachusetts Institute Of Technology | Method of promoting the regeneration of tissue at a wound |
US4787900A (en) * | 1982-04-19 | 1988-11-29 | Massachusetts Institute Of Technology | Process for forming multilayer bioreplaceable blood vessel prosthesis |
IL78950A (en) * | 1985-06-06 | 1991-12-15 | Univ Jefferson | Coating for prosthetic devices |
US5567612A (en) * | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
US5527532A (en) * | 1989-11-13 | 1996-06-18 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
WO1991007154A1 (en) * | 1989-11-13 | 1991-05-30 | President And Fellows Of Harvard College | EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO |
US5540928A (en) * | 1991-02-27 | 1996-07-30 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
ATE237682T1 (de) * | 1991-07-15 | 2003-05-15 | Oklahoma Med Res Found | Universale spenderzellen |
US5336615A (en) * | 1992-01-06 | 1994-08-09 | Yale University | Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity |
US5399665A (en) * | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
WO1995029713A1 (en) * | 1994-04-29 | 1995-11-09 | W.L. Gore & Associates, Inc. | Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix |
-
1995
- 1995-06-02 US US08/458,978 patent/US5766584A/en not_active Expired - Lifetime
-
1996
- 1996-05-09 AU AU62928/96A patent/AU714559B2/en not_active Expired
- 1996-05-09 DE DE69626290T patent/DE69626290T2/de not_active Expired - Lifetime
- 1996-05-09 CA CA002222497A patent/CA2222497C/en not_active Expired - Lifetime
- 1996-05-09 EP EP96915700A patent/EP0850073B1/de not_active Expired - Lifetime
- 1996-05-09 AT AT96915700T patent/ATE232748T1/de not_active IP Right Cessation
- 1996-05-09 WO PCT/US1996/006707 patent/WO1996038188A1/en active IP Right Grant
- 1996-05-09 JP JP53650296A patent/JP3941881B2/ja not_active Expired - Lifetime
-
2005
- 2005-05-20 JP JP2005148802A patent/JP2005254000A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1996038188A1 (en) | 1996-12-05 |
ATE232748T1 (de) | 2003-03-15 |
JPH11506364A (ja) | 1999-06-08 |
CA2222497C (en) | 2008-07-29 |
CA2222497A1 (en) | 1996-12-05 |
JP2005254000A (ja) | 2005-09-22 |
US5766584A (en) | 1998-06-16 |
AU6292896A (en) | 1996-12-18 |
JP3941881B2 (ja) | 2007-07-04 |
AU714559B2 (en) | 2000-01-06 |
DE69626290T2 (de) | 2003-12-04 |
EP0850073A1 (de) | 1998-07-01 |
EP0850073B1 (de) | 2003-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69626290T2 (de) | Hemmung von gefässverengungen nach eingriffen an den gefässen | |
Lynn et al. | Characterization of the in vitro macrophage response and in vivo host response to poly (ethylene glycol)‐based hydrogels | |
Ingram et al. | The use of ultrasonication to aid recellularization of acellular natural tissue scaffolds for use in anterior cruciate ligament reconstruction | |
Dunn et al. | Development of fibroblast‐seeded ligament analogs for ACL reconstruction | |
Chu et al. | Enhanced growth of animal and human endothelial cells on biodegradable polymers | |
Eweida et al. | Naturally occurring extracellular matrix scaffolds for dermal regeneration: do they really need cells? | |
Li et al. | Periosteum tissue engineering—a review | |
EP3213778B1 (de) | Zellen auf matrixunterlagen für die wiederherstellung von geweben | |
Keilhoff et al. | Bio-compatibility of type I/III collagen matrix for peripheral nerve reconstruction | |
EP0707498B1 (de) | Implantierbare prothese, kit und vorrichtung zu deren herstellung | |
Weigand et al. | The arteriovenous loop: engineering of axially vascularized tissue | |
ATE321573T1 (de) | Therapeutischer inhibitor von glatten muskelzellen | |
ES2004281A6 (es) | Una superficie protesica implantable para implantacion en un paciente humano | |
WO1998054301B1 (en) | Transplants for myocardial scars and method and cellular preparations therefor | |
ES8900149A1 (es) | Un metodo para tratar una protesis implantable, destinada a ser implantada en un paciente humano | |
CA2756818A1 (en) | Method of tissue repair | |
Tiwari et al. | Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate | |
Kangesu et al. | A porcine model using skin graft chambers for studies on cultured keratinocytes | |
CN108478863A (zh) | 复合小口径人工血管的制备方法及其产品 | |
Dutoya et al. | Elastin-derived protein coating onto poly (ethylene terephthalate). Technical, microstructural and biological studies | |
Lei et al. | Research on alginate-polyacrylamide enhanced amnion hydrogel, a potential vascular substitute material | |
Auger et al. | Role and innocuity of Tisseel®, a tissue glue, in the grafting process andin vivo evolution of human cultured epidermis | |
Titorencu et al. | In vitro biocompatibility of human endothelial cells with collagen-doxycycline matrices | |
Lin et al. | An animal study of a novel tri-layer wound dressing material—non-woven fabric grafted with N-isopropyl acrylamide and gelatin | |
Fimiani et al. | Other uses of homologous skin grafts and skin bank bioproducts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |